Indexed logomarkindexed.vc

Synvect

Eco-friendly mosquito control powered by CRISPR

La Jolla, United States · Founded 2024 · $3.0M raised

Healthcare
Biotech
Deep Tech
Headquarters
La Jolla, California
Founded
2024
Business Model
B2B
Website
synvect.com
Total Funding
$3.0M
Last Round
$3.0M SeedMar 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Synvect is a CRISPR-based biotechnology company developing an eco-friendly, effective, and evolutionary stable mosquito control platform. Built on 15 years of cutting-edge research and $20M in prior academic funding, the company's next-generation Sterile Insect Technique (ngSIT) technology leverages bioengineered mosquitoes to suppress disease-carrying populations without pesticides or environmental harm. Synvect targets the growing global burden of mosquito-borne diseases such as malaria, dengue, and Zika.

Summary

Synvect is a Healthcare company based in La Jolla, United States, founded in 2024. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Mar 2025. Investors include Bill & Melinda Gates Foundation, Antler and NuFund Venture Group.

LinkedIn

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2025
$3.0M

Investors

Bill & Melinda Gates Foundation

Lead

1 round

Antler

1 round

NuFund Venture Group

1 round

Redbud VC

1 round

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Appears in

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Synvect on Indexed.vc
<a href="https://indexed.vc/companies/synvect"><img src="https://indexed.vc/api/badge/company/synvect" alt="Synvect on Indexed.vc" width="260" height="76" /></a>